THE ROLE OF CLINICAL OUTCOME ASSESSMENT DATA IN THE DRUG APPROVAL PROCESS OF PRODUCTS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY IN THE USA AND EUROPE: A REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS